Global AI in Clinical Trials Market Research Report – Segmented By Clinical Trial Phase (Phase-I, Phase-II, Phase-III); By Application (Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others); By End User (Pharmaceutical Companies, Academia, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Global AI in Clinical Trials Market – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. Global AI in Clinical Trials Market – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

       2.3.1. Impact during 2023 - 2030

       2.3.2. Impact on Supply – Demand

Chapter 3. Global AI in Clinical Trials Market – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. Global AI in Clinical Trials Market Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. Global AI in Clinical Trials Market - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. Global AI in Clinical Trials Market – By Clinical Trial Phase

6.1. Phase-I

6.2. Phase-II

6.3. Phase-III

Chapter 7. Global AI in Clinical Trials Market – By By End User

7.1. Pharmaceutical Companies

7.2. Academia

7.3. Others

Chapter 8. Global AI in Clinical Trials Market – By Application

8.1. Oncology

8.2. Cardiovascular Diseases

8.3. Neurological Diseases or Conditions

8.4. Metabolic Diseases

8.5. Infectious Diseases

8.6. Others

Chapter 9. Global AI in Clinical Trials Market - By Region

9.1. North America

9.2. Europe

9.3. Asia-Pacific

9.4. Latin America

9.5. The Middle East

9.6. Africa

Chapter 10. Global AI in Clinical Trials Market – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

 

10.1 IBM Watson

10.2 Google-Verily

10.3 Euretos

10.4 Trials.Ai

10.5 Pharmaseal

10.6 DEEP LENS AI

10.7 AiCure, LLC

10.8 Symphony AI

10.9 Intelligencia

10.10 Innoplexus

10.11 Phesi

10.12 Saama Technologies

10.13 Exscientia

10.14 GNS Healthcare

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800